# Clinical Efficacy Trial of Mexiletine for Myotonic Dystrophy Type 1

> **NCT01406873** · PHASE2 · COMPLETED · sponsor: **University of Rochester** · enrollment: 42 (actual)

## Conditions studied

- Myotonic Dystrophy

## Interventions

- **DRUG:** Mexiletine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01406873
- **Lead sponsor:** University of Rochester
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-06
- **Primary completion:** 2017-02
- **Final completion:** 2017-03
- **Target enrollment:** 42 (ACTUAL)
- **Last updated:** 2018-06-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01406873

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01406873, "Clinical Efficacy Trial of Mexiletine for Myotonic Dystrophy Type 1". Retrieved via AI Analytics 2026-08-17 from https://api.ai-analytics.org/clinical/NCT01406873. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*